Mitochondrial acetylation and diseases of aging

Gregory R. Wagner, R. Mark Payne

Research output: Contribution to journalReview article

34 Scopus citations

Abstract

In recent years, protein lysine acetylation has emerged as a prominent and conserved regulatory posttranslational modification that is abundant on numerous enzymes involved in the processes of intermediary metabolism. Well-characterized mitochondrial processes of carbon utilization are enriched in acetyl-lysine modifications. Although seminal discoveries have been made in the basic biology of mitochondrial acetylation, an understanding of how acetylation states influence enzyme function and metabolic reprogramming during pathological states remains largely unknown. This paper will examine our current understanding of eukaryotic acetate metabolism and present recent findings in the field of mitochondrial acetylation biology. The implications of mitochondrial acetylation for the aging process will be discussed, as well as its potential implications for the unique and localized metabolic states that occur during the aging-associated conditions of heart failure and cancer growth.

Original languageEnglish (US)
Article number234875
JournalJournal of Aging Research
Volume2011
DOIs
StatePublished - Dec 1 2011

ASJC Scopus subject areas

  • Geriatrics and Gerontology

Fingerprint Dive into the research topics of 'Mitochondrial acetylation and diseases of aging'. Together they form a unique fingerprint.

  • Cite this